The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens

@article{VelzquezSnchez2013TheAD,
  title={The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens},
  author={Clara Vel{\'a}zquez-S{\'a}nchez and Jose Manuel Garc{\'i}a-Verdugo and Juan Murga and Juan J Canales},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={2013},
  volume={44},
  pages={73-80}
}

Figures from this paper

Modulation of Dopamine Transporter Function by Tamoxifen
TLDR
The selective estrogen receptor modulator tamoxifen has been demonstrated to increase extracellular dopamine in vivo and act as a neuroprotectant in models of dopamine neurotoxicity, but the nature and mechanism of these effects remains to be clarified.
Dual dopamine/serotonin treatment approach for addictive behaviour
TLDR
Test results with JHW add further support to this BZT analogue as a promising stimulant abuse medication and hypothesised that a combined DA/5-HT treatment would further attenuate MA-induced reinstatement.
Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption
TLDR
A reduction in food intake emerged after repeated administration of a low dose of JHW 007, and the benztropine analogs were more potent than cocaine and GBR 12909.
Preclinical Efficacy of N-Substituted Benztropine Analogs as Antagonists of Methamphetamine Self-Administration in Rats
TLDR
The present results suggest that the effects of BZT analogs on stimulant self-administration are similar to effects of µ-agonists on µ-agonist self- Administration and food prefeeding on food-reinforced responding, which implicates behavioral mechanisms for these effects and further supports development of atypical dopamine uptake inhibitors as medications for stimulant abuse.
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
TLDR
This review provides an overview of the current understanding of DAT and VMAT2 neurobiology, including discussion of studies ranging from those conducted in vitro to those involving human subjects and how selected drugs alter the function and expression of these transporters.
Relapse to cocaine seeking in an invertebrate
The Trace of Non-classical Biogenic Amines: A New Road to Addiction Recovery
TLDR
Evidence indicating that TAAR1 modulates the activity of the dopamine system and strongly influences the neurochemical and behavioral actions of psychomotor stimulants confirms the view thatTAAR1 is a promising candidate receptor for the design of new effective addiction therapies.
Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.
TLDR
A molecular dynamic simulation study supported the hypothesis that atypical DAT inhibitors have similar binding poses at DAT in a conformation that differs from that of cocaine, and may contribute to their unique behavioral profiles and potential for development as cocaine use disorder therapeutics.
...
...

References

SHOWING 1-10 OF 58 REFERENCES
The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization
Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
TLDR
A straightforward demonstration that a BZT derivative with binding affinity for DAT exhibits high efficacy in animal models of Amph abuse is provided, suggesting that the novel generation of BzT analogs could have wider therapeutic applications in stimulant-spectrum disorders than those previously recognized.
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
  • M. Wolf
  • Biology, Psychology
    Progress in Neurobiology
  • 1998
A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat
TLDR
Notably, the analog showed by comparison to cocaine weak reinforcing efficacy in a modified progressive ratio schedule of drug reinforcement, and contrary to cocaine, it showed no ability to promote context-conditioned relapse to drug seeking following stable self-administration and abstinence.
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies
TLDR
The distinctions between drugs in the induction and expression of sensitization indicate that behavioral sensitization can arise from multiple neuroadaptations in multiple brain nuclei, not only the result of distinct molecular targets for the drugs, but may also include a differential involvement of learned associations.
Persistent Structural Modifications in Nucleus Accumbens and Prefrontal Cortex Neurons Produced by Previous Experience with Amphetamine
TLDR
The ability of amphetamine to alter patterns of synaptic connectivity in brain regions that mediate its psychomotor activating and rewarding effects may contribute to some of the long-term behavioral consequences of repeated amphetamine use, including amphetamine psychosis and addiction.
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Nucleus accumbens lesions modulate the effects of methylphenidate
...
...